[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Page 69134]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27484]



[[Page 69134]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration: 
AMPAC Fine Chemicals, LLC.

    By Notice dated July 23, 2013, and published in the Federal 
Register on July 31, 2013, 78 FR 46372, AMPAC Fine Chemicals, LLC., 
Highway 50 and Hazel Avenue, Building 05001, Rancho Cordova, California 
95670, made application by renewal to the Drug Enforcement 
Administration (DEA) as a bulk manufacturer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methylphenidate (1724).....................  II
Thebaine (9333)............................  II
Poppy Straw Concentrate (9670).............  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company is a contract manufacturer. In reference to Poppy Straw 
Concentrate the company will manufacture Thebaine intermediates to sell 
to its customers for further manufacture. No other activity for this 
drug code is authorized for registration.
    No comments or objections have been received. Comments and requests 
for hearings on applications to import narcotic raw material are not 
appropriate. 72 FR 3417 (2007).
    DEA has considered the factors in 21 U.S.C. 823(a) and determined 
that the registration of AMPAC Fine Chemicals, LLC., to manufacture the 
listed basic classes of controlled substances is consistent with the 
public interest at this time.
    DEA has investigated AMPAC Fine Chemicals, LLC., to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: November 4, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-27484 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P